Silver Book

Silver Book Fact

AFib, an economic burden

Fact image

AFib is a major economic burden for the U.S. with at least $6.65 billion in healthcare costs attributable to the disease each year. This estimate may be low. One study estimates that Medicare alone pays $15.7 billion per year to treat newly diagnosed AFib patients.

Direct Treatment Cost of Atrial Fibrillation in the Elderly American Population: A Medicare perspective. J Med Econ. 2008; 11(2). http://www.ncbi.nlm.nih.gov/pubmed/19450086

Assessing the Direct Costs of Treating Nonvalvular Atrial Fibrillation in the United States. Value in Health. 2006; 9(5). http://www.ncbi.nlm.nih.gov/pubmed/16961553

Reference

Title
Direct Treatment Cost of Atrial Fibrillation in the Elderly American Population: A Medicare perspective
Publication
J Med Econ
Publication Date
2008
Volume & Issue
Volume 11, Issue 2
Pages
281-98
URL
Read Full Resource
Title
Assessing the Direct Costs of Treating Nonvalvular Atrial Fibrillation in the United States
Publication
Value in Health
Publication Date
2006
Volume & Issue
Volume 9, Issue 5
Pages
348-56
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • AFib-related stroke and disability
    Stroke is very disabling and individuals recovering from a stroke who also have AFib have a higher risk of remaining disable or handicapped compared to stroke patients without AFib.  
  • Atrial fibrillation stroke risk
    Atrial fibrillation (AF) increases the risk of severe and recurrent ischemic stroke. Patients not treated with anticoagulants have a 2.1-fold increase in risk of recurrent stroke and 2.4-fold increase in…  
  • Hospitalization costs for patients with nonrecurrent ischemic stroke
    The cost of hospitalization for patients with nonrecurrent ischemic stroke is $4,991 more in patients with atrial fibrillation, than in patients without the disease.        
  • AFib patient hospital visits
    Individuals with atrial fibrillation (AF) are 4 times more likely to visit the hospital 3 or more times in the year following an AF diagnosis—compared to those without the disease.  
  • Atrial Fibrillation prevalence increase from 1992 to 2002
    Among Medicare patients ages 65 and older, atrial fibrillation prevalence increased from 3.2% in 1992 to 6.0% in 2002–with higher prevalence in older patients.